GlySens Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:GlySens Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6612
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
GlySens Inc (GlySens) is a medical device company that offers glucose monitoring systems. The company develops GlySens ICGM system, a fully-implanted continuous glucose monitoring system intended to improve the lives of people with diabetes. GlySens offers continuous glucose sensor, which has been designed to function reliably as a long term implant in subcutaneous tissues. The company provides implant that contains two independent detectors in that first to measure glucose through a specific chemical reaction connecting glucose and oxygen, which is monitored by an electrochemical main detector; and second one is a reference detector that monitors background tissue oxygen levels. It offers long term ICGM Sensor, which is designed to be inserted by a brief outpatient procedure under local anesthesia and then measure interstitial fluid glucose levels in adults. GlySens is headquartered in San Diego, California, the US.

GlySens Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
GlySens Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
GlySens Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
GlySens Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
GlySens Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
GlySens Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
GlySens Inc, Medical Equipment, Deal Details 10
Venture Financing 10
GlySens Raises USD20 Million in Venture Financing 10
GlySens Raises USD12 Million in Series C Financing 11
GlySens Raises Funds Through Venture Financing 12
GlySens Inc – Key Competitors 13
GlySens Inc – Key Employees 14
GlySens Inc – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
GlySens Inc, Medical Equipment, Key Facts 2
GlySens Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
GlySens Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
GlySens Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
GlySens Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
GlySens Inc, Deals By Market, 2012 to YTD 2018 8
GlySens Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
GlySens Raises USD20 Million in Venture Financing 10
GlySens Raises USD12 Million in Series C Financing 11
GlySens Raises Funds Through Venture Financing 12
GlySens Inc, Key Competitors 13
GlySens Inc, Key Employees 14

List of Figures
GlySens Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
GlySens Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
GlySens Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
GlySens Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
GlySens Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
GlySens Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
GlySens Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
GlySens Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[GlySens Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Japan Tobacco Inc.:企業の戦略・SWOT・財務情報
    Japan Tobacco Inc. - Strategy, SWOT and Corporate Finance Report Summary Japan Tobacco Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Bourbon Corporation:企業の戦略・SWOT・財務情報
    Bourbon Corporation - Strategy, SWOT and Corporate Finance Report Summary Bourbon Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Roswell Park Cancer Institute-製薬・医療分野:企業M&A・提携分析
    Summary Roswell Park Cancer Institute (RPCI) is a cancer treatment institute that provides diagnosis, treatments and services for various kinds of cancer. The institute’s treatment includes advanced endoscopy, BMT, interventional pulmonology, interventional radiology, anesthesiologists, psychologist …
  • Vascular Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Vascular Pharmaceuticals Inc (VPI) is a biotechnology company that develops and commercializes therapeutics for the treatment of diabetes associated complications. The company develops pre clinical product candidate, VPI-2690B, for treating diabetic nephropathy. Its lead compound is a humani …
  • Weifa ASA (WEIFA)-石油・ガス分野:企業M&A・提携分析
    Summary Weifa ASA (Weifa), formerly Aqualis ASA, is a pharmaceutical company that conducts the research and development, manufacture, distribution and sales of pharmaceutical products, lifestyle products and solutions. The company has over the counter (OTC) pharmaceutical market in Norway offering p …
  • The Depository Trust & Clearing Corp:企業の戦略的SWOT分析
    The Depository Trust & Clearing Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Ontario Teachers’ Pension Plan:戦略・SWOT・企業財務分析
    Ontario Teachers' Pension Plan - Strategy, SWOT and Corporate Finance Report Summary Ontario Teachers' Pension Plan - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Destination Maternity Corporation (DEST):企業の財務・戦略的SWOT分析
    Destination Maternity Corporation (DEST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Leica Microsystems GmbH:企業のM&A・事業提携・投資動向
    Leica Microsystems GmbH - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Leica Microsystems GmbH Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Maxim Power Corp.:発電所・企業SWOT分析
    Maxim Power Corp. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees ( …
  • Spindletop Oil & Gas Co (SPND):企業の財務・戦略的SWOT分析
    Summary Spindletop Oil & Gas Co (Spindletop Oil & Gas) is an oil and gas exploration and production company. The company explores, develops and produces crude oil and natural gas in North America. It owns and maintains natural gas pipeline in Texas. Spindletop Oil & Gas also operates various gas pip …
  • PhoenixBio Co Ltd (6190)-製薬・医療分野:企業M&A・提携分析
    Summary PhoenixBio Co Ltd (PhoenixBio) is a life science company that offers medical therapy solutions. The company offers contract study services which include dosing of test-compounds, sampling, in-life phase trials, chemical analysis, measurement of human albumin levels, and metabolic enzymes and …
  • Teollisuuden Voima Oyj:企業の戦略的SWOT分析
    Teollisuuden Voima Oyj - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Hologic Inc (HOLX):医療機器:M&Aディール及び事業提携情報
    Summary Hologic Inc (Hologic) develops, manufactures and supplies diagnostic products, medical imaging systems, surgical products and light-based aesthetic and medical treatment systems. The company offers products to aid in the diagnosis of human diseases; breast imaging and related products and ac …
  • Nexter Group:企業の戦略・SWOT・財務情報
    Nexter Group - Strategy, SWOT and Corporate Finance Report Summary Nexter Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Rna Diagnostics Inc:企業の製品パイプライン分析2018
    Summary Rna Diagnostics Inc (Rna Diagnostics) is a medical device company that discovers and develops medical diagnostics molecular diagnostic technologies. The company offers diagnostic tools used in treatment of women undergoing chemotherapy for breast cancer. It also provides solutions to manage …
  • AmpliPhi Biosciences Corp (APHB):製薬・医療:M&Aディール及び事業提携情報
    Summary AmpliPhi Biosciences Corp (AmpliPhi) is a biotechnology company which focuses on development and commercialization of bacteriophage-based antibacterial therapeutics. The company by utilizing its proprietary bacteriophage technology developed a pipeline of products for the treatment of variou …
  • Formycon AG (FYB):企業の財務・戦略的SWOT分析
    Summary Formycon AG (Formycon) formerly Nanohale AG is a biopharmaceutical company that develops biosimilar drugs candidates. The company offers biopharmaceutical imitation products for global recovery. It provides four biosimilar products in pre-clinical and clinical testing phases. Formycon’s pipe …
  • MGC Diagnostics Corp (MGCD):企業の財務・戦略的SWOT分析
    Summary MGC Diagnostics Corp (MGC Diagnostics) is a medical device company that provides cardio respiratory health solutions. The company provides PFT, metabolic CPET and CPX and indirect calorimetry products. Its PFT products include plethysmograph, pulmonary function systems, spirometry and forced …
  • Teleperformance SE:企業の戦略・SWOT・財務情報
    Teleperformance SE - Strategy, SWOT and Corporate Finance Report Summary Teleperformance SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆